In vivo persistence and protective efficacy of the bacille Calmette Guerin vaccine overexpressing the HspX latency antigen.

In vivo persistence and protective efficacy of the bacille Calmette Guerin vaccine overexpressing the HspX latency antigen.

Item
http://www.wikidata.org/entity/Q34558242
Immunogenicity of a recombinant Mycobacterium smegmatis vaccine expressing the fusion protein CMX in cattle from Goiás State, Brazil.A new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis.Recombinant BCG as a vaccine vehicle to protect against tuberculosis.The in vivo environment accelerates generation of resuscitation-promoting factor-dependent mycobacteria.ESAT-6 and HspX improve the effectiveness of BCG to induce human dendritic cells-dependent Th1 and NK cells activation.Urease activity represents an alternative pathway for Mycobacterium tuberculosis nitrogen metabolism.HspX-mediated protection against tuberculosis depends on its chaperoning of a mycobacterial molecule.Antimicrobial treatment improves mycobacterial survival in nonpermissive growth conditions.Understanding the biology of 16 kDa antigen of Mycobacterium tuberculosis: scope in diagnosis, vaccine design and therapy.Virulence factors of the Mycobacterium tuberculosis complexPrime-boost vaccination strategy with bacillus Calmette-Guérin (BCG) and liposomized alpha-crystalline protein 1 reinvigorates BCG potency.The mc2-CMX vaccine induces an enhanced immune response against Mycobacterium tuberculosis compared to Bacillus Calmette-Guérin but with similar lung inflammatory effects.
P2860

In vivo persistence and protective efficacy of the bacille Calmette Guerin vaccine overexpressing the HspX latency antigen.

Item
http://www.wikidata.org/entity/Q34558242
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
In vivo persistence and protec ...... sing the HspX latency antigen.
@ast
In vivo persistence and protec ...... sing the HspX latency antigen.
@en
In vivo persistence and protec ...... sing the HspX latency antigen.
@nl
type
label
In vivo persistence and protec ...... sing the HspX latency antigen.
@ast
In vivo persistence and protec ...... sing the HspX latency antigen.
@en
In vivo persistence and protec ...... sing the HspX latency antigen.
@nl
prefLabel
In vivo persistence and protec ...... sing the HspX latency antigen.
@ast
In vivo persistence and protec ...... sing the HspX latency antigen.
@en
In vivo persistence and protec ...... sing the HspX latency antigen.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
In vivo persistence and protec ...... sing the HspX latency antigen.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932